Minnetronix, Inc., a St. Paul, MN-based medical technology and innovation company, raised $20m in equity funding.
Altaris Capital Partners, LLC, made a minority investment in the company.
The company intends to use the funds to pursue its growth strategies.
Launched in 1996 and led by Rich Nazarian, president and CEO, Minnetronix supports companies in designing, engineering and manufacturing electronic and electromechanical medical devices. Working with small startups and medical device corporations alike, Minnetronix has helped develop technologies and products in the cardiovascular, oncology, pulmonary, neurology, and wound care markets, among others.
The company has more than 200 employees.
Minnetronix is FDA Registered and ISO 13485 Certified.